M. Dalmark
- Molecular Biology top 10%
- Physiology top 5%
- Oncology top 5%
- Pediatrics, Perinatology and Child Health top 5%
- Cell Biology top 10%
- Co-authors
- J O WiethAlbert CassHans H. StormD. C. TostesonRobert B. GunnLars BastholtElse K. HoffmannOle S. Nielsen
- Topics
- Chemotherapy-induced cardiotoxicity and mitigation (12 papers)Cancer Treatment and Pharmacology (11 papers)Erythrocyte Function and Pathophysiology (7 papers)
- Cited by
- PhysiologyOncologyBiophysics
- Journals
- Journal of Clinical OncologyThe Journal of PhysiologyBiochimica et Biophysica Acta (BBA) - Biomembranes
- Partner nations
- DenmarkUnited StatesSweden
In The Last Decade
M. Dalmark
34 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 107
- Molecular Biology 908
- Physiology 574
- Oncology 498
- Pediatrics, Perinatology and Child Health 222
- Cell Biology 190
Countries citing papers authored by M. Dalmark
This map shows the geographic impact of M. Dalmark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Dalmark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Dalmark more than expected).
Fields of papers citing papers by M. Dalmark
This network shows the impact of papers produced by M. Dalmark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Dalmark. The network helps show where M. Dalmark may publish in the future.
Co-authorship network of co-authors of M. Dalmark
This figure shows the co-authorship network connecting the top 25 collaborators of M. Dalmark. A scholar is included among the top collaborators of M. Dalmark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Dalmark. M. Dalmark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 135 | |
| 2 | 36 | |
| 3 | 13 | |
| 4 | 34 | |
| 5 | 49 | |
| 6 | 11 | |
| 7 | 45 | |
| 8 | 4 | |
| 9 | 22 | |
| 10 | 15 | |
| 11 | Phase II study of idarubicin given orally in the treatment of anthracycline-naive advanced breast cancer patients. | 24 |
| 12 | 32 | |
| 13 | 131 | |
| 14 | 46 | |
| 15 | 26 | |
| 16 | Chloride in the human erythrocyte: distribution and transport between cellular and extracellular fluids and structural features of the cell membrane. | 33 |
| 17 | 136 | |
| 18 | 209 | |
| 19 | 12 | |
| 20 | 6 |
About M. Dalmark
M. Dalmark is a scholar working on Biophysics, Gastroenterology and Cardiology and Cardiovascular Medicine, having authored 34 papers that have together received 1.7k indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (12 papers), Cancer Treatment and Pharmacology (11 papers) and Erythrocyte Function and Pathophysiology (7 papers). The work is most often cited by research in Physiology (574 citations), Oncology (498 citations) and Biophysics (79 citations). M. Dalmark has collaborated with scholars based in Denmark, United States and Sweden. Frequent co-authors include J O Wieth, Albert Cass, Hans H. Storm, D. C. Tosteson, Robert B. Gunn, Lars Bastholt, Else K. Hoffmann, Ole S. Nielsen, Susanne B. Gjedde and Peter Johansen. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Physiology and Biochimica et Biophysica Acta (BBA) - Biomembranes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.